{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T04:01:17Z","timestamp":1768536077200,"version":"3.49.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","license":[{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,24]]},"abstract":"<jats:p>To assess the metastatic pattern in pelvic and para-aortic lymph nodes in relation with the primary uterine tumor site and to evaluate risk factors for lymph node metastases. 212 patients with endometrial cancer who underwent surgical treatment from December 2014 to December 2019 were selected. The clinical and pathological data were retrospectively analyzed. The factors and uterine primary tumor site related to lymph node metastasis were analyzed by univariate and multivariate analysis. Among the 212 patients with endometrial cancer, 17 cases had lymph node metastasis, and thus the metastasis rate was 8.02%. Univariate analysis revealed that lymph node metastasis was significantly correlated with Federation of Gynecology and Obstetrics stage, depth of myometrial invasion, tumor size, pathological grade, and lymphovascular space invasion (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05) and was not correlated with age, pathological type, and cervical involvement (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&gt;\u2005.05). Primary uterine tumor site (fundus, horns, body or lower uterine segment) with or without cervical involvement was associated with different lymph nodes\u2019 metastatic sites. The lymph node metastatic pathways of endometrial cancer mainly include obturator lymph nodes and para-aortic lymph nodes, and skip metastasis may occur; endometrial carcinoma may jump and metastasize to para-aortic lymph nodes, specially when the lesion is located in the uterine fundus and uterine horns (cornua of uterus); there is a significant correlation between the location of lymph node metastasis and the location of primary uterine malignant tumor.<\/jats:p>","DOI":"10.1097\/md.0000000000036100","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T19:05:12Z","timestamp":1701716712000},"page":"e36100","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Investigating the influence of primary uterine tumor site on pelvic and para-aortic lymph node metastatic pattern and evaluating the risk factors for lymph node metastases in endometrial carcinoma: A retrospective study"],"prefix":"10.1097","volume":"102","author":[{"given":"Xiao","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China"},{"name":"Key Laboratory of Reproductive Dysfunction Management of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saihua","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Zhejiang People\u2019s Hospital, Tiantai Branch, Taizhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangxiao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China"},{"name":"Key Laboratory of Reproductive Dysfunction Management of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limei","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China"},{"name":"Key Laboratory of Reproductive Dysfunction Management of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanliang","family":"Shang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China"},{"name":"Key Laboratory of Reproductive Dysfunction Management of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianqiong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China"},{"name":"Key Laboratory of Reproductive Dysfunction Management of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojing","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China"},{"name":"Key Laboratory of Reproductive Dysfunction Management of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7834-4001","authenticated-orcid":false,"given":"Jianhua","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China"},{"name":"Key Laboratory of Reproductive Dysfunction Management of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250524","first-page":"1987","article-title":"[The incidence and mortality of endometrial cancer in China, 2015].","volume":"102","author":"Sun","year":"2022","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"R2-20250524","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021.","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R3-20250524","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1158\/1055-9965.EPI-04-0871","article-title":"Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention.","volume":"14","author":"Bray","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R4-20250524","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1186\/s12885-021-08466-4","article-title":"A nomogram prediction model for lymph node metastasis in endometrial cancer patients.","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Cancer"},{"key":"R5-20250524","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023.","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"R6-20250524","doi-asserted-by":"crossref","first-page":"170","DOI":"10.6004\/jnccn.2018.0006","article-title":"Uterine neoplasms, version 12018, NCCN clinical practice guidelines in oncology.","volume":"16","author":"Koh","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"R7-20250524","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2217\/fon-2020-0017","article-title":"Clinicopathological study of organ metastasis in endometrial cancer.","volume":"16","author":"Mao","year":"2020","journal-title":"Future Oncol"},{"key":"R8-20250524","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ijgo.13140","article-title":"HE4 tumor marker as a predictive factor for lymphatic metastasis in endometrial cancer.","volume":"149","author":"Espiau Romera","year":"2020","journal-title":"Int J Gynaecol Obstet"},{"key":"R9-20250524","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3322\/caac.21561","article-title":"Current recommendations and recent progress in endometrial cancer.","volume":"69","author":"Brooks","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"R10-20250524","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/9781118298565.ch135","article-title":"Pelvic and para-aortic lymphadenectomy in gynecologic cancers.","author":"Singh","year":"2016","journal-title":"Gynecol Obstetr Surg"},{"key":"R11-20250524","first-page":"125","article-title":"Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study [published correction appears in Lancet 2009 May 23;373(9677):1764].","volume":"373","author":"Kitchener","year":"2009","journal-title":"Lancet"},{"key":"R12-20250524","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","article-title":"Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.","volume":"100","author":"Benedetti Panici","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R13-20250524","first-page":"CD007585","article-title":"Lymphadenectomy for the management of endometrial cancer.","volume":"10","author":"Frost","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R14-20250524","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3906\/sag-1602-137","article-title":"Is lower uterine segment involvement a prognostic factor in endometrial cancer?","volume":"47","author":"Erkaya","year":"2017","journal-title":"Turk J Med Sci"},{"key":"R15-20250524","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1102\/1470-7330.2013.0011","article-title":"Typical and atypical metastatic sites of recurrent endometrial carcinoma.","volume":"13","author":"Kurra","year":"2013","journal-title":"Cancer Imaging"},{"key":"R16-20250524","first-page":"167","article-title":"Lymph node pathway in the spread of endometrial carcinoma.","volume":"26","author":"Jobo","year":"2005","journal-title":"Eur J Gynaecol Oncol"},{"issue":"Suppl 1","key":"R17-20250524","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ijgo.13866","article-title":"Cancer of the corpus uteri: 2021 update.","volume":"155","author":"Koskas","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"R18-20250524","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/IGC.0000000000000937","article-title":"Lymph node metastasis in patients with endometrioid endometrial cancer: overtreatment is the main issue.","volume":"27","author":"Karalok","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"R19-20250524","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","article-title":"Endometrial cancer.","volume":"399","author":"Crosbie","year":"2022","journal-title":"Lancet"},{"key":"R21-20250524","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/annonc\/mdv484","article-title":"ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up.","volume":"27","author":"Colombo","year":"2016","journal-title":"Ann Oncol"},{"key":"R22-20250524","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ygyno.2011.07.025","article-title":"Evaluating the significance of location of lymph node metastasis and extranodal disease in women with stage IIIC endometrial cancer.","volume":"123","author":"Garg","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R23-20250524","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ijgo.13309","article-title":"Relationship of lymph node status with survival and recurrence among women with endometrial cancer.","volume":"151","author":"Buldukoglu","year":"2020","journal-title":"Int J Gynaecol Obstet"},{"key":"R24-20250524","doi-asserted-by":"crossref","first-page":"1295613","DOI":"10.1155\/2020\/1295613","article-title":"Effect of lymphadenectomy on survival in early-stage type II endometrial carcinoma and carcinosarcoma.","volume":"2020","author":"Vatansever","year":"2020","journal-title":"J Oncol"},{"key":"R25-20250524","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00404-020-05600-8","article-title":"Systematic lymphadenectomy in early stage endometrial cancer.","volume":"302","author":"Ignatov","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"R26-20250524","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ijgo.13228","article-title":"Para-aortic lymphadenectomy did not improve overall survival among women with type I endometrial cancer.","volume":"150","author":"Li","year":"2020","journal-title":"Int J Gynaecol Obstet"},{"key":"R27-20250524","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/jog.12344","article-title":"Role of pelvic and para-aortic lymphadenectomy in endometrial cancer: current evidence.","volume":"40","author":"Bogani","year":"2014","journal-title":"J Obstet Gynaecol Res"},{"key":"R28-20250524","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ijgo.14307","article-title":"Sentinel lymph node mapping in endometrial cancer: a comparison of main national and international guidelines.","volume":"160","author":"Dick","year":"2022","journal-title":"Int J Gynaecol Obstet"},{"key":"R29-20250524","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00404-019-05276-9","article-title":"Risk factors for pelvic lymph node metastasis in endometrial cancer.","volume":"300","author":"Li","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"R30-20250524","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/IGC.0000000000001290","article-title":"Influence of prognostic factors on lymph node involvement in endometrial cancer: a single-center experience.","volume":"28","author":"Widschwendter","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"R31-20250524","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1245\/s10434-021-11083-x","article-title":"Predictive score of nodal involvement in endometrial cancer patients: a large multicentre series.","volume":"29","author":"Capozzi","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"R32-20250524","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ygyno.2019.08.005","article-title":"Comparing risk stratification criteria for predicting lymphatic dissemination in endometrial cancer.","volume":"155","author":"Kilts","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R33-20250524","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/IGC.0000000000001223","article-title":"Tumor size, an additional risk factor of local recurrence in low-risk endometrial cancer: a large multicentric retrospective study.","volume":"28","author":"Sozzi","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"R34-20250524","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(18)30079-2","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.","volume":"19","author":"de Boer","year":"2018","journal-title":"Lancet Oncol"},{"key":"R35-20250524","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1097\/IGC.0b013e3182a16c93","article-title":"Lymphovascular space invasion (LVSI) is an isolated poor prognostic factor for recurrence and survival among women with intermediate- to high-risk early-stage endometrioid endometrial cancer.","volume":"23","author":"Weinberg","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"R36-20250524","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s10147-017-1139-5","article-title":"Risk factors for paraaortic lymph node metastasis in endometrial cancer.","volume":"22","author":"Sari","year":"2017","journal-title":"Int J Clin Oncol"},{"key":"R37-20250524","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1080\/0284186X.2019.1643036","article-title":"Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer \u2013 a Swedish Gynecologic Cancer Group (SweGCG) study.","volume":"58","author":"Stalberg","year":"2019","journal-title":"Acta Oncol"},{"key":"R38-20250524","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1053\/j.sult.2019.04.001","article-title":"Imaging and staging of endometrial cancer.","volume":"40","author":"Faria","year":"2019","journal-title":"Semin Ultrasound CT MR"},{"key":"R39-20250524","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/AOG.0b013e3181f73fc2","article-title":"Cervical stromal invasion predicting survival in endometrial cancer.","volume":"116","author":"Ferriss","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"Iss 1 Suppl 1","key":"R40-20250524","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1097\/PGP.0000000000000524","article-title":"Pathologic prognostic factors in endometrial carcinoma (Other than tumor type and grade).","volume":"38","author":"Singh","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"R41-20250524","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1525-1438.2007.00996.x","article-title":"The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology.","volume":"18","author":"Chi","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"R42-20250524","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer.","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet"},{"key":"R43-20250524","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejogrb.2009.12.021","article-title":"Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status.","volume":"149","author":"Fotopoulou","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R44-20250524","doi-asserted-by":"crossref","first-page":"e9520","DOI":"10.1097\/MD.0000000000009520","article-title":"Survival benefits of pelvic lymphadenectomy versus pelvic and para-aortic lymphadenectomy in patients with endometrial cancer: a meta-analysis.","volume":"97","author":"Guo","year":"2018","journal-title":"Medicine (Baltim)"},{"key":"R45-20250524","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s00261-012-9915-1","article-title":"Preoperative evaluation of myometrial invasion in endometrial carcinoma: diagnostic performance of 3T MRI.","volume":"38","author":"Dogan","year":"2013","journal-title":"Abdom Imaging"},{"key":"R46-20250524","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ygyno.2011.09.013","article-title":"Lymph node metastasis in stages I and II ovarian cancer: a review.","volume":"123","author":"Kleppe","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R47-20250524","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ygyno.2012.06.018","article-title":"Lymph node metastasis in endometrioid adenocarcinomas of the uterine corpus with occult cervical involvement.","volume":"127","author":"Boren","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R48-20250524","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/ijc.30707","article-title":"Risk factors for lymph node metastases in women with endometrial cancer: a population-based, nation-wide register study\u2014on behalf of the Swedish Gynecological Cancer Group.","volume":"140","author":"Stalberg","year":"2017","journal-title":"Int J Cancer"},{"key":"R49-20250524","doi-asserted-by":"crossref","first-page":"106952","DOI":"10.1016\/j.ejso.2023.06.004","article-title":"Hysteroscopic endometrial tumor localization and sentinel lymph node mapping. An upgrade of the hysteroscopic role in endometrial cancer patients [published online ahead of print, 2023 Jun 10].","volume":"49","author":"Capozzi","year":"2023","journal-title":"Eur J Surg Oncol"},{"key":"R50-20250524","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1200\/JCO.2002.20.3.688","article-title":"Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy.","volume":"20","author":"Levenback","year":"2002","journal-title":"J Clin Oncol"},{"key":"R51-20250524","doi-asserted-by":"crossref","first-page":"678.e1","DOI":"10.1016\/j.ajog.2007.09.053","article-title":"Where to look for the sentinel lymph node in cervical cancer.","volume":"197","author":"Bader","year":"2007","journal-title":"Am J Obstet Gynecol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036100","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T18:02:04Z","timestamp":1748109724000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":50,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000036100","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,24]]}}}